코스닥 이야기
Quickly browse recent reports in the selected category.
-
![[KOSDAQ Story] Responding to the KOSDAQ 150 Volatility Expansion Phase: Analysis of Active ETF Supply/Demand and Foreign Program Trading](https://daily-stock.kr/stdaily/uploads/202603/gen_69be507c42df05.62814958.png)
[KOSDAQ Story] Responding to the KOSDAQ 150 Volatility Expansion Phase: Analysis of Active ETF Supply/Demand and Foreign Program Trading
Hello, as a professional writer for Daily Stock, I welcome you all who are contemplating successful investment strategies today. Image generation: "A 16:9 thumbnail image for a financial blog, showing a dramatic stock chart ...
-
![[KOSDAQ Retail Top Net Purchases Review] The Majesty of 1st Place Beating Ecopro, Analysis of Samchundang Pharm's Oral Insulin Momentum](https://daily-stock.kr/stdaily/uploads/202603/gen_69bcfefd8fdfb1.30890448.png)
[KOSDAQ Retail Top Net Purchases Review] The Majesty of 1st Place Beating Ecopro, Analysis of Samchundang Pharm's Oral Insulin Momentum
Hello, this is Daily Stock. We review the strong net buying trend of retail investors defending the KOSDAQ 1160 line amid NASDAQ's extreme fear, focusing on Samchundang Pharm using the latest data as of March 20, 2026.
-
KOSDAQ Surpasses 1140: Examining the 'Reversal Bets' in Retail Investors' Portfolios
Hello, I'm an expert writer for Daily Stock. Today, we examine the trends and backgrounds of key stocks heavily net-bought by retail investors as the KOSDAQ breaks the 1140 mark.